Amyloid β Peptide Peptides
Inhibitors |
|
| Cat. No. | Product Name / Activity |
|---|---|
| 6779 | Davunetide |
| Highly potent active component of ADNP; prevents amyloid β aggregation; active in vivo | |
Other |
|
| Cat. No. | Product Name / Activity |
| 1191 | Amyloid β-Peptide (1-40) (human) |
| Amyloid β-protein fragment | |
| 1428 | Amyloid β-Peptide (1-42) (human) |
| Predominant amyloid β-protein fragment | |
| 2425 | Amyloid β-peptide (1-42) (rat) |
| Predominant amyloid β-protein fragment | |
| 1429 | Amyloid β-peptide (25-35) (human) |
| Human amyloid β-protein fragment functionally required for neurotoxicity | |
| 3945 | Colivelin |
| Neuroprotective peptide; protects against β-amyloid neurotoxicity | |
| 6517 | Liraglutide |
| Reduces Aβ and soluble amyloid levels in vivo; also highly potent GLP-1 receptor agonist | |
| 7712 | Semax |
| Reduces Aβ aggregation and fibrillogenesis; neuroprotective and neurotrophic peptide | |